Uganda Introduces Cabotegravir for HIV Prevention
The Ministry of Health Uganda has announced that it is set to introduce a new long-acting injectable for HIV prevention, cabotegravir (CAB-LA), beginning this September. Cabotegravir tablets and cabotegravir extended-release injectable suspension (also known as long-acting injectable cabotegravir) can be used for pre-exposure prophylaxis (PrEP) to reduce the risk of getting HIV in people who…
